SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-030815
Filing Date
2024-06-21
Accepted
2024-06-21 07:30:32
Documents
4
Period of Report
2024-07-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20030506x3_def14a.htm DEF 14A 404912
2 logo_neximmune.jpg GRAPHIC 39342
3 ny20030506x3_pc01.jpg GRAPHIC 625659
4 ny20030506x3_pc02.jpg GRAPHIC 682919
  Complete submission text file 0001140361-24-030815.txt   2261392
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40045 | Film No.: 241058347
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)